|Bid||79.82 x 900|
|Ask||79.91 x 2200|
|Day's Range||78.98 - 80.67|
|52 Week Range||59.60 - 88.87|
|PE Ratio (TTM)||90.87|
|Earnings Date||Oct 24, 2018 - Oct 29, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||87.64|
Global Medidata CSR Activities this Summer Include All Star Code in New York, New Parklets in London, the Cures Within Reach Global Health Awards in Chicago, and More
While Medidata had a solid quarter, subscription growth was a concern for a JPMorgan analyst who downgraded the stock to neutral. Whirlpool Corporation shares saw their worst day of trading on Tuesday since 1987 as tariffs affected the company in its latest quarterly results.
On a per-share basis, the New York-based company said it had net income of 27 cents. Earnings, adjusted for one-time gains and costs, came to 43 cents per share. The results exceeded Wall Street expectations. ...
NEW YORK, NY / ACCESSWIRE / July 24, 2018 / Medidata Solutions, Inc. (NASDAQ: MDSO ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 24, 2018 at 8:00 AM Eastern Time. ...
SHYFT Analytics, a Medidata Solutions (MDSO) company, announced today that Novartis has selected its Intelligent Platform for Life Sciences to support the commercialization of key therapies in Europe. Together, these solutions simplify and accelerate the aggregation, assimilation, and analysis of scores of disparate data sets that inform commercial sales and medical education programs. “Pharma companies are acutely aware of the tremendous demands on healthcare professionals’ time.
China Drug Administration and Celltrion Lead Keynote Sessions
Medidata , today announced that it will release its second quarter 2018 financial results before the open of the market on Tuesday, July 24, 2018. The Company will also hold a conference call at 8:00 a.m.
NEW YORK, June 28, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Health ...
With China based customers doubling in 2017, Medidata announced the appointment of Jim Xu as general manager in the market, and plans to double the size of local talent.
To make clinical research truly patient-centric, Medidata announced the launch of the Patient Burden Index on the Medidata Cloud, the Intelligent Platform for Life Sciences.
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Medidata Solutions Inc (NASDAQ:MDSO) with a market-capitalization of US$4.88b, rarely draw their attention. Despite this, the twoRead More...
Medidata Solutions Inc., a publicly traded provider of cloud-based software for collecting and managing clinical-trial data, has agreed to acquire a company it had previously backed—Shyft Analytics Inc.--for ...
Medidata (MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics. The combined platform seamlessly delivers market-leading applications, services, and proven data science capabilities, powered by the largest global pool of research data, companies’ own CRM data, 3rd party commercial data, and real-world data sources. Pharmaceutical, biotech, and medical device companies now have an unprecedented ability to manage and optimize value across the clinical and commercial continuum.
Gains were broad based as eight out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Healthcare Information Services stocks: Cerner Corp. (NASDAQ: CERN), Cotiviti Holdings Inc. (NYSE: COTV), Inovalon Holdings Inc. (NASDAQ: INOV), and Medidata Solutions Inc. (NASDAQ: MDSO).
Medidata announced that Memorial Sloan Kettering Cancer Center is using Rave Omics with Biomarker Discovery for patients with pancreatic cancer, an example of the paradigm shift in clinical trials through the systematic capture of genomic data and the application of artificial intelligence algorithms.
For the second consecutive year, Medidata will be presenting its pioneering analytics innovation during the 2018 ASCO Annual Meeting. The hour-long “Industry Expert Theater” session*, Integration of Genomics Data and Analysis in Oncology Research, will occur on June 2 at 9:30 AM CDT at the Oncology Professionals Hall, McCormick Place Convention Center in Chicago.
Medidata Solutions Inc (NASDAQ:MDSO) is trading with a trailing P/E of 96.9x, which is higher than the industry average of 45x. While MDSO might seem like a stock to avoidRead More...